Confronting the bias towards animal experimentation (animal methods bias)

Catharine E. Krebs, Kathrin Herrmann
{"title":"Confronting the bias towards animal experimentation (animal methods bias)","authors":"Catharine E. Krebs, Kathrin Herrmann","doi":"10.3389/fddsv.2024.1347798","DOIUrl":null,"url":null,"abstract":"Laws and policies are in place around the world to promote the replacement and reduction of nonhuman animals in science. These principles are rooted not just in ethical considerations for animals, but also in scientific considerations regarding the limitations of using nonhuman animals to model human biology, health, and disease. New nonanimal research approaches that use human biology, cells, and data to mimic complex human physiological states and therapeutic responses have become increasingly effective and accessible, replacing the use of animals in several applications, and becoming a crucial tool for biomedical research and drug development. Despite many advantages, acceptance of these new nonanimal methods has been slow, and barriers to their broader uptake remain. One such barrier is animal methods bias, the preference for animal-based methods where they are not necessary or where animal-free methods are suitable. This bias can impact research assessments and can discourage researchers from using novel nonanimal approaches. This article provides an introductory overview of animal methods bias for the general public, reviewing evidence, exploring consequences, and discussing ongoing mitigation efforts aimed at reducing barriers in the shift away from animal use in biomedical research and testing.","PeriodicalId":507971,"journal":{"name":"Frontiers in Drug Discovery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Drug Discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fddsv.2024.1347798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Laws and policies are in place around the world to promote the replacement and reduction of nonhuman animals in science. These principles are rooted not just in ethical considerations for animals, but also in scientific considerations regarding the limitations of using nonhuman animals to model human biology, health, and disease. New nonanimal research approaches that use human biology, cells, and data to mimic complex human physiological states and therapeutic responses have become increasingly effective and accessible, replacing the use of animals in several applications, and becoming a crucial tool for biomedical research and drug development. Despite many advantages, acceptance of these new nonanimal methods has been slow, and barriers to their broader uptake remain. One such barrier is animal methods bias, the preference for animal-based methods where they are not necessary or where animal-free methods are suitable. This bias can impact research assessments and can discourage researchers from using novel nonanimal approaches. This article provides an introductory overview of animal methods bias for the general public, reviewing evidence, exploring consequences, and discussing ongoing mitigation efforts aimed at reducing barriers in the shift away from animal use in biomedical research and testing.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
正视对动物实验的偏见(动物实验方法偏见)
世界各地都制定了法律和政策,促进在科学研究中取代和减少非人类动物。这些原则不仅植根于对动物的伦理考虑,也植根于对使用非人类动物模拟人类生物学、健康和疾病的局限性的科学考虑。新的非动物研究方法利用人体生物学、细胞和数据来模拟复杂的人体生理状态和治疗反应,已变得越来越有效和容易获得,在一些应用中取代了动物的使用,成为生物医学研究和药物开发的重要工具。尽管这些新的非动物实验方法有许多优点,但接受的速度一直很慢,而且在更广泛地采用这些方法方面仍然存在障碍。其中一个障碍就是动物方法偏见,即在没有必要使用动物方法或适合使用无动物方法的情况下,偏好使用动物方法。这种偏见会影响研究评估,并阻碍研究人员使用新型非动物方法。本文向公众介绍了动物方法偏差,回顾了相关证据,探讨了其后果,并讨论了为减少生物医学研究和测试中不再使用动物的障碍而正在进行的缓解努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The role of physicochemical and topological parameters in drug design Editorial: Recent trends in anti-cancer drug discovery by in silico methods A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival A review on dynamics of permeability-glycoprotein in efflux of chemotherapeutic drugs The (misleading) role of animal models in drug development
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1